Skip to main content

Advertisement

Table 4 Tumor response

From: Phase I clinical trial of autologous NK cell therapy using novel expansion method in patients with advanced digestive cancer

No. of patients Response Response rate (%) (95 % CI) Disease control rate (%) (95 % CI)
CR PR SD PD
ITT population n = 12 0 0 5 7 0 (0) 41.7 (15.17–72.33)
PP population n = 10 0 0 5 5 0 (0) 50.0 (18.71–81.29)
  1. ITT intention -to-treat, PP per protocol, CR complete response, PR Partial response, SD stable disease, PD progressive disease, 95 %CI 95 % confidence interval